Le Lézard
Classified in: Health
Subject: SVY

Optogenetics Actuators and Sensors - Worldwide Market Analysis & Forecast 2018-2025: The High Cost of Technology is Hampering Growth


DUBLIN, Nov 19, 2018 /PRNewswire/ --

The "Optogenetics Actuators and Sensors Market Analysis Report By Product, By Disease Type (Retinal Disorders, Parkinson's Disease, Schizophrenia, Autism, Depression & Anxiety), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global optogenetics actuators & sensors market size is expected to reach USD 584.73 million by 2025, exhibiting a 1.93% CAGR during the forecast period.

Extensive research in the field of neuroscience and ophthalmology is expected to boost market growth in the coming years. Key players are focusing majorly on research activities to study brain functions in various psychiatric and retinal disease states, which is anticipated to drive the sector.

Government organizations are providing funds to academic research institutions and individual researchers for advancements in the field of optogenetics. Moreover, various initiatives undertaken by international organizations such as WHO and NIH are anticipated to boost market growth. Various projects and initiatives initiated in the field of neuroscience are also promoting growth prospects.

In addition, ongoing investigations to improve signal sizes and responses and target specificity of subcellular membranes such as axon terminals, cell body, and dendrites in neuroscience are expected to support the growth of the segment. Rise in incidence of retinal and brain disorders are ultimately increasing demand for optogenetic actuators and sensors.

Furthermore, changing healthcare reforms and public-private collaborations among industrial players, government, and research institutions are expected to drive technological progressions in optogenetics. This, in turn, is anticipated to significantly boost the growth of the optogenetics actuators and sensors market over the forecast period.

Further key findings from the report suggest:

Key Topics Covered

Chapter 1 Research Methodology
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 Internal database
1.2 Data Analysis
1.3 Market Formulation & Validation

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Growing use of optogenetics in the field of neuroscience
3.1.1.2 Government initiatives & funding opportunities
3.1.1.3 Rising burden of neurological & retinal disorders
3.1.2 Market restraint analysis
3.1.2.1 High cost of technology
3.1.2.2 Ethical regulations for animal welfare
3.2 Penetration & Growth Prospect Mapping for Methods, 2016
3.3 Optogenetics Actuators & Sensors Market-SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
3.4 Industry Analysis - Porter's

Chapter 4 Market Categorization: Products Estimates & Trend Analysis
4.1 Global Optogenetic Actuators & Sensors Market: Product Movement Analysis
4.2 Actuators
4.3 Sensors

Chapter 5 Market Categorization: Disease Type Estimates & Trend Analysis
5.1 Global Optogenetic Actuators & Sensors Market: Disease Type Movement Analysis
5.2 Retinal Disorders
5.3 Parkinson's Disease
5.4 Anxiety & Depression
5.5 Autism
5.6 Schizophrenia
5.7 Others

Chapter 6 Market Categorization: Regional Estimates & Trend Analysis by Product & Disease Type
6.1 Global Optogenetics Actuators & Sensors Market Share by Region, 2016 & 2025
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Latin America
6.6 Middle East & Africa (MEA)

Chapter 7 Competitive Landscape
7.1 List of Companies
7.2 Market Participation Categorization
7.3 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/468ls6/optogenetics?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

SOURCE Research and Markets


These press releases may also interest you

at 17:48
On Wednesday, April 17, the San Joaquin Valley Health Fund (SJVHF) launched "Equity on the Road" a multi-city series of community town halls to deepen local understanding of state issues and to advocate for more resources in the San Joaquin Valley....

at 17:44
The Honourable Mark Holland, Minister of Health, will host an event at the University of Waterloo to highlight the federal budget's investments to support students. The Minister will be joined by Bryan May, Parliamentary Secretary to the Minister of...

at 17:31
The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness. Moreover,...

at 17:00
Avicanna Inc. ("Avicanna" or the "Company") a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that it has closed a non-brokered private...

at 16:46
Darling Ingredients Inc. announced today that it will host a conference call on Thursday, April 25, 2024, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss first quarter 2024 financial results, which will be released earlier that day, and...

at 16:45
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumor resection for patients with anaplastic...



News published on and distributed by: